Clinical Trial Update: Timely Detection of Treatment Emergent Serious and Non-serious Adverse Events for Saxenda® in Mexican Patients

View source ↗

Summary

A clinical trial update reports on monitoring treatment-emergent adverse events with Saxenda (liraglutide) in Mexican patients. The update focuses on the detect…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• SAXENDA (liraglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Obesity | Status: COMPLETED